Thymoma-associated myasthenia gravis: Clinical features and surgical results

被引:7
|
作者
Bouchikh, M. [1 ,2 ]
El Malki, H. O. [2 ]
Ouchen, F. [1 ]
Achir, A. [1 ]
Benosman, A. [1 ]
机构
[1] CHU Ibn Sina, Serv Chirurg thorac, Rabat Principale 10001, Morocco
[2] Univ Mohamed V Souissi, Fac Med & Pharm Rabat, CRECET, Rabat 8007, Morocco
关键词
Myasthenia gravis; Thymoma; Surgery; Thymectomy; Complete stable remission; THYMECTOMY; PREDICTORS;
D O I
10.1016/j.neurol.2013.01.625
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. The aim of this study was to compare the characteristics of myasthenic patients with and without thymoma, and the results of thymectomy in both types of patients. Material and methods. - A retrospective study was conducted among 66 patients who underwent thymectomy for myasthenia gravis in our department over a 10-year period (2000-2010). The surgical approach was sternotomy or anterolateral thoracotomy. Patients were divided into two groups according to the presence of thymoma: with (T-MG) and without (NT-MG) thymoma. Complete stable remission (CSR) was the primary endpoint. Results. - Median age was 35.09 +/- 9.89 years. The NT-MG group had 38 patients (57.57%) and the T-MG group 28 patients (42.43%). There was no difference between the two groups regarding the surgical approach (P = 0.52). T-MG patients were older (40.54 +/- 15.16 vs. 31.37 +/- 9.46) (P = 0.008) and predominantly male. There were more generalized forms (P = 0.01) and more bulbar involvement (P = 0.02) in the T-MG group. The rate of CSR at 5 years was 7% and 17% in the T-MG and NT-MG patients respectively (P = 0.70). At 10 years, it was 36% and 94.73% respectively (P = 0.03). Conclusion. - Thymomatous myasthenia gravis is characterized by the severity of its clinical features. Remission rate at 10 years was significantly lower in the myasthenia with thymoma group. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:879 / 883
页数:5
相关论文
共 50 条
  • [1] Thymoma-associated myasthenia gravis: clinical features and surgical results
    Yuceyar, A. N.
    Uluakay, A.
    Uncu, G.
    Ekmekci, O.
    Karasoy, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 721 - 721
  • [2] Clinical characteristics and outcomes of thymoma-associated myasthenia gravis
    Alvarez-Velasco, Rodrigo
    Gutierrez-Gutierrez, Gerardo
    Carlos Trujillo, Juan
    Martinez, Elisabeth
    Segovia, Sonia
    Arribas-Velasco, Marina
    Fernandez, Guillermo
    Paradas, Carmen
    Velez-Gomez, Beatriz
    Casasnovas, Carlos
    Nedkova, Velina
    Guerrero-Sola, Antonio
    Ramos-Fransi, Alba
    Martinez-Pineiro, Alicia
    Pardo, Julio
    Sevilla, Teresa
    Gomez-Caravaca, Maria Teresa
    Lopez de Munain, Adolfo
    Jerico, Ivonne
    Pelayo-Negro, Ana L.
    Asuncion Martin, Maria
    Morgado, Yolanda
    Dolores Mendoza, Maria
    Perez-Perez, Helena
    Rojas-Garcia, Ricard
    Turon-Sans, Janina
    Querol, Luis
    Gallardo, Eduard
    Illa, Isabel
    Cortes-Vicente, Elena
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (06) : 2083 - 2091
  • [3] Evolution of thymoma-associated Myasthenia gravis
    Nacu, A.
    Lisnic, V.
    Munteanu, L.
    Grosu, C.
    JOURNAL OF NEUROLOGY, 2012, 259 : S208 - S208
  • [4] Thymoma-Associated Myasthenia Gravis With Myocarditis
    Sarwar, Shihab
    Oyewunmi, Oyebimbola
    Bhola, Karundat
    Heydari, Bobak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [5] Clinical and pathologic predictors of outcome in thymoma-associated Myasthenia gravis
    López-Cano, M
    Ponseti-Bosch, JM
    Espin-Basany, E
    Sánchez-García, JL
    Armengol-Carrasco, M
    ANNALS OF THORACIC SURGERY, 2003, 76 (05): : 1643 - 1649
  • [6] Immunodeficiency in patients with thymoma-associated myasthenia gravis
    Ishizuchi, Kei
    Takizawa, Tsubasa
    Ohnuki, Yuko
    Sekiguchi, Koji
    Motegi, Haruhiko
    Oyama, Munenori
    Nakahara, Jin
    Shiina, Takashi
    Suzuki, Shigeaki
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 371
  • [7] Erythroderma in a Patient With Thymoma-Associated Myasthenia Gravis
    Chen, Jia-Qi
    Li, Wei
    Cai, Sui-Qing
    JAMA DERMATOLOGY, 2024, 160 (02) : 224 - 225
  • [8] THYMOMA-ASSOCIATED ANTIGENS IN MYASTHENIA-GRAVIS
    GILHUS, NE
    AARLI, JA
    MATRE, R
    TONDER, O
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1984, 20 (02) : 171 - 171
  • [9] Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma
    De Rosa, Anna
    Fornili, Marco
    Maestri Tassoni, Michelangelo
    Guida, Melania
    Baglietto, Laura
    Petrucci, Loredana
    Chella, Antonio
    Melfi, Franca
    Lucchi, Marco
    Ricciardi, Roberta
    THORACIC CANCER, 2021, 12 (01) : 106 - 113
  • [10] Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study
    Gastaldi, M.
    De Rosa, A.
    Maestri, M.
    Zardini, E.
    Scaranzin, S.
    Guida, M.
    Borrelli, P.
    Ferraro, O. E.
    Lampasona, V.
    Furlan, R.
    Irani, S. R.
    Waters, P.
    Lang, B.
    Vincent, A.
    Marchioni, E.
    Ricciardi, R.
    Franciotta, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (07) : 992 - 999